Selection of optimal quantity of hydroxyethyl starch in the cardiopulmonary bypass prime

Abstract

Ringer’s solution prime reduces colloid osmotic pressure and causes edema during cardiopulmonary bypass, while hydroxyethyl starch (HES) can be used to attenuate this effect. Fifty patients were classified into five equal groups: Group I (preoperative patients) is the control group and the other four groups (II, III, IV, V) received different volume ratios of Ringer’s solution to HES (1:0, 2:1, 1:2, 0:1, respectively). This study was aimed at evaluating the optimal quantity of HES regarding body fluids expansion, ventilation and recovery time, blood rheologic properties, clotting parameters, platelet counts, blood loss and red blood cell membrane properties. The results showed a reduction in interstitial fluid (ISF) expansion, changes in blood rheologic properties with the increase in HES quantity and shorter ventilation and recovery times in Groups IV and V. We concluded that the optimal HES quantity in the prime is two thirds, which insures an 85% reduction of ISF relative to Group II, shorter ventilation and recovery times and avoidance of the hazards of high levels of HES.

Get full access to this article

View all access options for this article.

References

Eising G , Niemeyer M , Günther T et al.

Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery?

Eur J Cardiothorac Surg 2001; 20: 282-289 .

Ng CS , Wan S , Yim AP , Arifi AA. Pulmonary dysfunction after cardiac surgery . Chest 2002; 121: 1269-1277 .

Boldt J.

Volume therapy in cardiac surgery: does the kind of fluid matter?

J Cardiothorac Vasc Anesth 1999; 13: 752-763 .

Warren B , Durieux M.

Hydroxyethyl starch: safe or not?

Anesth Analg 1997; 84: 206-212 .

Boldt J , Knothe C , Zickman B , Andres P , Dapper F , Hewpelmann G. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass . Anesth Analg 1993; 76: 1185-1190 .

Crispell K , Porter B , Nieset R. Studies of plasma volume using human serum albumin tagged with radioactive iodine . J Clin Invest 1949; 28: 1117-1117 .

Lote C. The body fluids; body fluid compartments: method of measurement. In Principles of renal physiology, third edition. Chapman-Hall , 1994: 15-17.

Davidson D , Sackner M. Simplification of the anthrone method for determination of inulin in clearance studies . J Lab Clin Med 1963; 62: 351-356 .

Dacie J , Lewis S. Use of radionuclides in haematology. In Practical Haematology, sixth edition. Churchill Livingstone , 1984: 152-156, 274-275 and 420-422.

10.

Jansen P , te Velthuis H , Wildevuur WR et al. Cardiopulmonary bypass with modified fluid gelatin and heparin-coated circuits . Br J Anaesth 1996; 76: 13-19 .

11.

Boldt J , Kling D , Zickmann B et al. Acute plasmapheresis during cardiac surgery: volume replacement by crystalloids versus colloids . J Cardiothorac Anesth 1990; 4: 564-570 .

12.

Laubenthal H , Messmer K. Pharmacology of dextrans. In Baron J ed. Plasma volume expansion. Paris: Arnette , 1992: 75-83.

13.

Sade RM , Stroud MR , Crawford FA Jr. , Kratz JM , Dearing JP , Bartles DM. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer’s solution as priming fluid for cardiopulmonary bypass . J Thorac Cardiovasc Surg 1985; 89: 713-722 .

14.

Mishler JM. Pharmacology of hydroxyethyl starch. Use in therapy and blood banking. Oxford: Oxford University Press , 1982: 1-30.

15.

Stone H , Thomson H , Schmidt-Nielsen K. Influence of erythrocytes on blood viscosity . Am J Physiol 1968; 214: 913-918 .

16.

London M , Ho J , Triedman J et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma expansion after cardiac operations . J Thoracic Cardiovasc Surg 1989; 97: 785-797 .

17.

Kameneva M , Undar A , Antaki J. Decrease in red blood cell deformability caused by hypothermia, hemodilution, and mechanical stress: factors related to cardio-pulmonary bypass . ASAIO J 1999; 45: 307-310 .